Kindred Healthcare Inc (KND) Drops 7.53% on January 25

Equities Staff |

Kindred Healthcare Inc (KND) was one of the Russell 2000's biggest losers for Monday January 25 as the stock slid 7.53% to $8.97, a loss of $-0.73 per share. Starting at an opening price of $9.62 a share, the stock traded between $8.89 and $9.71 over the course of the trading day. Volume was 808,226 shares over 5,900 trades, against an average daily volume of 1.33 million shares and a total float of 83.8 million.

The losses send Kindred Healthcare Inc down to a market cap of $751.66 million. In the last year, Kindred Healthcare Inc has traded between $24.66 and $8.45, and its 50-day SMA is currently $11.81 and 200-day SMA is $17.72.

Kindred Healthcare Inc is a healthcare services company. The Company through its subsidiaries operates hospitals, nursing centers and a contract rehabilitation services business across the United States.

Kindred Healthcare Inc is based out of Louisville, KY and has some 61,500 employees. Its CEO is Benjamin A. Breier.

For a complete fundamental analysis analysis of Kindred Healthcare Inc, check out Equities.com’s Stock Valuation Analysis report for KND. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Pinterest

Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…